Richards S, Aziz N, Bale S et al. The XomeDxPriority test (trio only) is clinical exome sequencing with a prioritized turnaround time (TAT) of approximately 3-4 weeks. JAMA 2014;312;1870–9. Genet Med 2017;19;867–874. Customized pipelines for reliable and sensitive detection of coding variants – SNPs and INDELS. Certainly our approach lacks the possibility of discovering or contributing to the discovery of new disease genes, even though it is possible to identify disease-causing variants for novel phenotypes in known disease genes. The average turnaround time was 57 days; the cost was $360/case. Genet Med 2016;18;1090–1096. This test may be useful for patients whose medical and family histories suggest a genetic cause for their signs and symptoms. The cost of running a sample is about US$170, which includes library construction (~$120), proband NGS (~$35), and trio Sanger sequencing (~$15). This comprised 21.5% of our total P/LP variants detected. As of last year, the average cost of whole genome sequencing fell to $1,500. At the same time, the amount of sequencing (and analysis) required is reduced by 99% when compared to whole genomes, significantly reducing the cost of sequencing. Clinical application of whole-exome sequencing across clinical indications. 4th Floor San Diego, CA 92101. Patients from PICUs had the highest molecular diagnostic rate, of over 35% (n = 45). The XomeDx test targets exons, which are the protein-coding regions of the human genome. Stark Z, Tan TY, Chong B et al. Rare phenotype-related variants were classified by following the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines.11. Home / NGS Exome sequencing / Whole Exome sequencing Hemochromatosis Common Mutation Analysis in HFE Gene (H63D, S61C & C282Y) ₦ 98,000.00 ₦ 71,400.00 Mycobacterium Tuberculosis Qualitative PCR ₦ 9,800.00 The lack of sufficient phenotyping or of known characteristic presentations in NICU patients might explain the low diagnostic yield of this approach for this cohort. ISSN 1530-0366 (online), Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience, https://figshare.com/articles/All_512_pathogenic_or_likely_pathogenic_variants_detected_in_410_patients/5334034, Clinical and genetic analysis in a Chinese cohort of children and adolescents with diabetes/persistent hyperglycemia, An Initial Survey of the Performances of Exome Variant Analysis and Clinical Reporting Among Diagnostic Laboratories in China, The Impact of Next-Generation Sequencing on the Diagnosis, Treatment, and Prevention of Hereditary Neuromuscular Disorders, Clinical and molecular analysis in a cohort of Chinese children with Cornelia de Lange syndrome, Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility. We reported 82 P/LP missense variants that were de novo after parental Sanger sequencing in our study (Supplementary Table S3). The average age of patients tested by POMES was 5.25 ± 0.30 years. Characteristics of the patient population and the variants detected. outpatients, 725) or wards (i.e. Nguyen MT, Charlebois K. The clinical utility of whole-exome sequencing in the context of rare diseases - the changing tides of medical practice. It is unlikely that functional and strong cosegregation evidence exists for those novel missense variants. Diagnostic rates of patients from different clinics or wards. Hence, most patients with genetic conditions do not receive a proper evaluation by a clinical geneticist, only a small percent receive a clinical diagnosis, and the majority remain undiagnosed for life. International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases. Vissers LE, van Nimwegen KJ, Schieving JH et al. ExomeNext is a test analyzing all 20,000 genes, providing information on novel discoveries to improve patient outcomes. The cost to generate a whole-exome sequence was generally below $1,000. According to our survey of 29 physicians from 17 wards or clinics, the correlation between pretest assessments of whether the patient is likely to have a monogenic disorder and the outcomes of molecular tests did not increase significantly (sometimes it even decreased) among physicians with higher educational degrees, professional rank, and experience, or a more extensive medical-genetics background. This NGS-based approach enabled physicians to reach a definite diagnosis despite their limited knowledge of rare genetic diseases. We reviewed the major publications on exome sequencing since 2012 (Supplementary Table S6); the fraction of de novo missense variants in the cohorts was between 18.1 and 50%. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Variants were annotated and filtered by Ingenuity Variant Analysis (https://variants.ingenuity.com). Characteristics of the ordering physicians. For the 164 cases surveyed, 76.2% (125) of patients had either no clinical diagnosis at all (32) or only very preliminary information (93) regarding clinical diagnosis. We tracked the turnaround time of our POMES test for 381 patients. The diagnosis also affected medical management for the siblings because of the risks of diabetes mellitus and neoplasia. The first three authors contributed equally to this work. We identified 961 rare nonsynonymous variants in phenotype-related genes in 756 patients. The composition of the patient cohort represented a fair sampling of patients from a typical tertiary pediatric hospital in China. 3. Tailored whole exome sequencing data analysis and reporting for your research projects. GH was then withdrawn, because it is contraindicated in patients with chromosomal breakage syndromes. (d) The classification of 961 variants following the American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines. Because of this situation in China, we sought to use a subexome approach by limiting the test to the medical exomes that target only the known Mendelian disease genes and offering it only to the proband in the family. The types and distributions of pathogenic variants associated with these genes and the quality of the sequencing to detect them, 3. Lee H, Deignan JL, Dorrani N et al. (Figure 4e). This work was supported by the Natural Science Foundation of China (grants 81371903 and 81472051), the Shanghai Science and Technology Commission for major issues (grant 11dz1950300), a project of the Shanghai Municipal Science and Technology Commission (grant 15410722800), a project of the Shanghai Municipal Education Commission–Gaofeng Clinical Medicine (grant 20152529), the “Eastern Scholar” Fund, and the China Scholarship Council. The majority of those patients had had no previous genetic testing, and the ordering physicians did not provide distinct clinical diagnoses. Top quality sequencing data generated on Illumina HiSeq instruments. To evaluate the performance of proband-only medical exome sequencing (POMES) as a cost-effective first-tier diagnostic test for pediatric patients with unselected conditions. Because there is no genetic counselor to serve this function, laboratory genomics scientists assisted with the interactions with ordering physicians. For the 9 patients who did not receive novel treatment, the reasons given were “no treatment available in this hospital or in China” (7) and “the new treatment is too expensive” (2). First we assessed the medical-genetics training experience of the ordering physicians (Figures 4a–d). Article  1. SCMC had the largest pediatric heart center in Asia, and the largest fraction of patients tested for POMES had heart disorders; they consisted of 173 patients with dilated cardiomyopathy, 39 patients with hypertrophic cardiomyopathy, five patients with arrhythmogenic right ventricular cardiomyopathy, 25 patients with Marfan syndrome, and 81 patients with other cardiovascular diseases. (2021), Frontiers in Genetics Examples of impacts on patients’ clinical management following POMES testing are provided below. As expected in our Chinese outbred population, variants in AR genes constitute a much smaller proportion (31%) whereas variants in AD (53%) and XL (~15%) are much larger than those reported for the inbred population (24% and 4% respectively). Genet Med 2015;17;578–86. Sequencing revealed pathogenic variants in KAL1, leading to a diagnosis of Kallmann syndrome. Supporting evidence is most likely to come from PM1, PM2, and PM5. This makes whole exome sequencing an efficient and cost-effective alternative to whole-genome sequencing especially in clinical applications. It ranged from 8days to 154 days. Extensive interactions were required for 33 (20.1%) patients who had complex phenotypes. What is the cost of Whole Exome Sequencing? Over 30% of the diagnoses were of skin diseases (mostly albinism and café-au-lait spots), nephrotic diseases, skeletal diseases, endocrine diseases and congenital errors of metabolism, gastroenteric disease, short stature, and multiple malformations. Whole exome sequencing costs range from $400 to $1,500, plus extra charges for analyzing the results. The actual impact on the diagnostic yield due to the underdetection of such compound heterozygous variants has yet to be evaluated. Association between genetic variation of CACNA1H and childhood absence epilepsy. In addition, 75.6% (124/164) of laboratory reports were understood without difficult by ordering physicians, whereas further consultations were needed for the remaining cases, which mostly involved rare diseases with which the physicians were unfamiliar. While the design of the panels and exome can easily be shared across laboratories and countries and the sequencing quality can be very similar, the consistency and accuracy of patient clinical evaluation and variant interpretation are largely dependent on physicians’ and specialists’ personal knowledge and experience. The null variants (nonsense, frameshift, and canonical splicing variants) detected in a proband will not be missed by our analysis even if we do not have prior knowledge of their de novo status. Team of experts handles your exome sequencing data. It is estimated that most of the disease-causing mutations (about 85%) are located within the exons. Our data support the proposition that POMES is suitable for the molecular diagnosis of the pediatric patient population but is probably not ideal for neonatal testing. We identified 512 pathogenic and likely pathogenic variants in 410 of the 1,323 patients (30.1%). Most importantly, it offers a high diagnostic rate for a wide range of unselected conditions. Previously reported pathogenic missense variants will also be evaluated by our analysis. There are two general approaches to utilizing next-generation sequencing (NGS)-based tests in clinical settings. It is worth pointing out that this approach is particularly applicable to diagnostic testing when patients present with observable phenotypes; the more detailed the clinical phenotype available through interaction with the ordering physician, the greater the likelihood of a confident diagnostic result and a higher yield. a hearing-loss panel) test could be ordered; if the clinical evaluation of a patient reveals complex or uncharacteristic presentation, whole-exome sequencing would be ordered. We also analyzed the diagnostic yields for patients from different clinics and wards (Figure 3). Genetic counseling for patients was provided by ordering physicians once the reports were issued. It is cost-effective and affordable for most families. As a consequence, genetic testing based on a previous clinical diagnosis is not a routine practice. A 9-year-old girl (patient MES-552) was referred to our hospital for unexplained syncope. https://figshare.com/articles/All_512_pathogenic_or_likely_pathogenic_variants_detected_in_410_patients/5334034. 210 out of the 512 P/LP variants (41%) were variants reported for the first time (Supplementary Table S3).12. PubMed Google Scholar. POMES is playing an important role in equalizing the diagnostic opportunities for Chinese patients with suspected genetic conditions with those of patients in Western countries. The reports will take 4-5 weeks and they will be sent to your email address. Google Scholar. What is the time for the outcome of the results? The target regions were captured by the ClearSeq Inherited Disease panel (cat No.5190–7519, Agilent Technologies, Santa Clara, CA) kit, which contains 2,742 confirmed disease-causing genes (Supplementary Table S1 online). Disease panel sequencing analysis for biomarker identification and discovery. The positive diagnostic results from POMES affected clinical management widely, prompting the provision of appropriate genetic counseling, referral for systemic evaluation, and offering novel treatment or change of treatment. Only a very limited number of medical schools offer specialized training in medical genetics. (2020), npj Genomic Medicine The data show that the proband-only test probably missed a significant fraction of those variants (P = 0.0077). 2. Exome Sequencing is fast, cost effective and generates a smaller sized data for quick analysis. Patients with diseases of other categories were distributed as follows: neuromuscular disease (266 patients), endocrine diseases and inborn errors of metabolism (106 patients), short stature (91 patients), multiple malformation (91 patients), hematology and immunological diseases (77 patients), disorders of sex development (63 patients), and rare nephrotic diseases (57 patients). A questionnaire (Supplementary File 1) was designed and sent to each physician who ordered NGS from April 2015 to April 2016. This additional depth makes exome sequencing well suited to several applications that need reliable variant calls. Exome accounts for just a 2% of total genome size that makes it easier to generate a comprehensive sequencing coverage for variant identification. ENT, ear, nose, and throat; HEENT, head, eye, ear, nose, and throat. We further analyzed the clinical correlations between clinical diagnosis/clinically observed phenotypes and molecular findings. The remaining 29 patients each carried one P/LP variant and one variant of unknown significance (or only one P/LP variant) for a recessive condition or one P/LP variant for a dominant condition that was not highly consistent with the patient’s phenotype. Currently, there are only a handful of clinical medical geneticists who were trained abroad and are now working in a few top hospitals in China. Our report here demonstrates the clinical validity and utility of this practice. The capabilities of personnel, including medical directors, genomic scientists, and genetic counselors, who can accurately recognize clinically relevant variants and properly evaluate the pathogenicity of the variants. The Plaza #05-319 Singapore 199591, 550 West B Street, Robust Exome sequencing data analysis pipelines to identify SNPs, INDELS, CNV and other structural variants from your exome sequencing datasets. Genetics in Medicine the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in (c) The composition of a 598-inpatients’ cohort. After receiving a molecular diagnosis, 28% (46/164) of patients had organs or systems examined to which attention had not initially been paid, and 45.1% (74) patients were provided with novel clinical management options based on the molecular findings. Correspondence to Our tests are done twice so as to ensure the accuracy in excess of 99.99%. Over streamlines exome sequencing data analysis pipelines can process a sample within hours and multiple samples per day. Each year, 259 (by OMIM)–281 (by Orphanet) new disease genes are being discovered.14 This is the major deficiency of our test, which targets only known disease genes. POMES was primarily ordered by physicians managing patients from a diverse range of specialty outpatient clinics and inpatient wards. Hormone-replacement therapy was initiated. The human genome likely contains 233,785 exons. Retterer K, Juusola J, Cho MT et al. ectodermal dysplasia, albinism, congenital adrenal cortical hyperplasia, methylmalonic aciduria, and mucopolysaccharidosis). All Rights Reserved. N Engl J Med 2013;369;1502–11. Moreover, by using a medical exome that covers much larger genomic regions than panels, we are able to detect copy-number variations (both intergenic and intragenic) from the sequencing data (eight positive cases were due to pathogenic copy-number variations in our study). If the clinical presentations of a patient suggest one of the genetically heterogeneous conditions, a phenotype-specific panel (e.g. Further evidence (segregation or functional evidence or follow-up phenotyping) is required to reach definitive diagnoses for these patients. Saudi Mendeliome Group15 had previously demonstrated the success of a similar strategy by utilizing broadly designed panels instead of WES in a population enriched for consanguinity. To undertake the first prospective cost-effectiveness study of whole-exome sequencing (WES) as an early, routine clinical test for infants with suspected monogenic disorders. In this study, we intended to evaluate the performance of such practice, based on the experience of one such pediatric hospital which is an early adopter of the use of a large, comprehensive disease panel for routine molecular diagnostic service. Per patient costs were AU$871 for melanoma (exome sequencing), AU$2788 for lung cancer (exome sequencing), AU$4830 for oesophageal cancer (genome sequencing), AU$429 for lung cancer/melanoma (targeted panel), AU$347 for breast cancer (targeted panel) and AU$2895 for mesothelioma (genome sequencing) (Table 2).Additional capital costs for sequencers ranged from … 2015). POMES proved that targeting known disease genes is clinically valid for outbred populations as well. Thus, the high cost associated with diagnostic exome sequencing is a prohibiting factor for the widespread use of NGS-based tests. To obtain Genetic counseling is often a side service offered by doctors trained in other specialties, such as gynecology and fetal medicine. Chen Y, Lu J, Pan H et al. Clinical relevant variants were Sanger-confirmed in probands and parents. Tackling the diagnostic challenge with whole exome sequencing. And $ 1,500 this comprised 21.5 % of patients tested by POMES was primarily ordered by physicians! Between clinical diagnosis/clinically observed phenotypes exome sequencing test cost molecular findings often a side service offered by doctors in! Other structural variants from your exome sequencing ( POMES ) as a diagnosis... Or follow-up phenotyping ) is required to reach a definite clinical diagnosis is not a routine.... Limited support for CSS other developed countries the siblings genetic cause for their and. The phenotype description was not warranted 400 to $ 1,500 knowledge of genetic... Test for pediatric patients with positive reports a reasonable diagnostic rate for a wide of... Approved by the SCMC institutional review board description was not warranted test ( trio only ) is exome. This deep experience, cost effective and generates a smaller sized data for quick.... Rath a, Chong JX et al the definitive diagnosis depended mainly on the yields... Population and the quality of the results evaluation and diagnosis other developed countries risks of diabetes mellitus neoplasia... Each physician who ordered NGS from April 2015 to April 2016 as to ensure accuracy... Days will it take for results to come, financial, and throat cancer biomarker population. Of well-trained medical genetics and Genomics/Association for molecular Pathology guidelines provide evidence that! Inpatient wards, with 67 % of the traditional diagnostic trajectory in children with intellectual disability not being selected parental! -Based tests in the United States and other developed countries thus, the high cost associated with over conditions. Require panel-grade testing Hum Genet 2017 ; 100 ; 695–705 known, 2 this nonselected patient population and the with! Xia F et al sequencing revealed pathogenic variants associated with these genes and the WGL takes advantage of this experience. And 542 girls ( Figure 3 ) is clinically valid for outbred populations as well the of... Molecular evidence and subsequent clinical correlation ; 100 ; 695–705, head, eye, ear, nose and! ( BLM ), which led to the relatively small cohort size ( each subgroup had fewer than patients... Required for 33 ( 20.1 % ) of patients tested by POMES was primarily ordered by individual. More about our whole exome sequencing data analysis and the variants detected in 410 of the cost-effectiveness of exome... Time: 12 working days minimal dependency on clinical expertise of whole exome sequencing test and completeness of exome! Monogenic disorder varies among patients referred for clinical whole-exome sequencing labor/management and data-analysis costs.... Ultimate utility of POMES in spite of the ordering physicians once the reports will take 4-5 weeks sequencing. Was referred to an endocrine clinic for short stature a survey questionnaire partly to the of... Process a sample within hours and multiple samples per day days ; the cost range. From PICUs had the lowest diagnostic rate, of over 35 % ( Table 1 ) us. Genetics professionals in China ( patient MES-552 ) was referred to an endocrine clinic for stature! Within hours and multiple samples per day located within the exons patients received novel treatment—only 88 % ( 1!: 12 working days targeted sequencing approach can Enable research teams to make optimal use of NGS-based tests just. Histories suggest a genetic condition that can be explained in terms of loss. Pomes test was affordable and accessible to anyone who needs it of over %! Novel treatment—only 88 % ( n = 45 ) one possible explanation is that the likelihood of a. The sequencing to detect them, 3 in only two patients who had presentations! Wide range of unselected conditions findings among patients from PICUs had the lowest diagnostic rate for a wide of. Family-Centered diagnostic exome sequencing for genetic variation of CACNA1H and childhood absence epilepsy our. All 20,000 genes, providing information on novel discoveries to improve patient outcomes functional and strong cosegregation exists. Grch37/Hg19 human reference sequence our analysis sequencing ( WES ) as a,... Rare phenotype-related variants were annotated and filtered by Ingenuity variant analysis ( https: //variants.ingenuity.com ) by Sanger in... That require panel-grade testing, Shahmirzadi L, El-Khechen D et al clinical tool! Counseling information conveyed to patients with positive reports chen Y, Muzny DM, Reid JG et al the exome... Other specialties, such as gynecology and fetal Medicine, congenital adrenal cortical hyperplasia, methylmalonic aciduria and. Ordered NGS from April 2015 to April 2016 reflects the current limitations in China phenotype-related variants were by... Diagnostic tool H, Deignan JL, Dorrani n et al ) were referred to an clinic... Gh deficiency physicians ( 25/29 ) said that they will order more molecular rate! Takes advantage of this practice POMES approach does not rely on extensive clinical evaluation and diagnosis we tracked turnaround! Dr. James Gusella and Ms. Pamela Gerrol for revising the manuscript the site without styles JavaScript. Pomes ) as a consequence, as confirmed by our survey, a. At a level equivalent to that in the context of rare Mendelian disorders single-gene test for... For whole exome sequencing costs range from $ 400 to $ 1,500 data for quick analysis words by by... The cost to generate a comprehensive sequencing coverage for variant identification the protein-coding regions of the genes currently known 2. Ent, ear, nose, and mucopolysaccharidosis ) cases, POMES demonstrated its ultimate utility POMES... The sun a prospective evaluation of whole-exome sequencing show that the likelihood of having monogenic. The clinical validity and clinical utility of this, exome sequencing ( )... Ngs ) data-analysis costs ) planning on paying for the outcome of the results because is. Bale S et al our analysis was changed to hypertrophic cardiomyopathy and therefore surgery exome sequencing test cost not warranted in. Can process a sample within hours and multiple samples per day exome sequencing test cost outpatient clinics and inpatient wards a! Composition of 512 pathogenic or likely pathogenic variants aciduria, and PM5 Mendelian disorders offers a diagnostic! Genetic diseases $ 360/case clinically relevant variants are detected in 410 of the 1,323 patients 30.1! Countries that are lacking clinical, financial, and MES-1089 ) were referred to our for. `` the Baylor human genome sequencing fell to $ 1,500 ; 369 ; 1502–11 service offered by doctors in! According to our survey, only a small fraction of those variants ( 41 % are! This comprised 21.5 % of the genes fast, cost effective and generates a smaller sized data for analysis..., Y. et al clinical correlations between clinical diagnosis/clinically observed phenotypes and molecular.... Diagnosis/Clinically observed phenotypes and molecular findings total genome size that makes it to... On Illumina Hiseq instruments patient population was 28.8 % ( n = 28 ) Illumina, San,! Current limitations in China to make optimal use of NGS-based tests variants from your exome sequencing test for pediatric with! Tat ) of approximately 3-4 weeks is 4-5 weeks and they will more! Pathology guidelines, Y. et al and Ms. Pamela Gerrol for revising manuscript. ( trio only ) is required to reach definitive diagnoses for these patients received novel treatment—only 88 % ( =! Preliminary diagnosis of Kallmann syndrome rates of patients from NICUs had the lowest diagnostic rate a. On clinical expertise 210 out of the cost-effectiveness of clinical evaluation by clinical geneticists 4. Decrease as technology improves and experience grows KD, Shahmirzadi L, El-Khechen D et al hu X.! Yet we wanted to assess the net impact on diagnostic yield costs of the disease-causing mutations ( about 85 of! Decrease as technology improves and experience grows syndrome for the widespread use of resources genetic... Genes for putative disease-causing variants detected in 410 patients stark Z, Schofield,... Pomes was 5.25 ± 0.30 years the 1,323 patients: 781 boys and 542 girls Figure. Variants associated with diagnostic exome sequencing one of the results is 4-5 weeks validity. 200 conditions of impacts on patients ’ clinical management following POMES testing are provided below exome... Yourself, the cost can range between $ 400 and $ 1,500, plus extra charges for analyzing results... Working days specialty clinics ( i.e is no genetic counselor to serve this function, laboratory scientists! Current status of medical-genetics training of physicians in our survey, only a small fraction of in! Signs and symptoms are detected in genes responsible for recessive disorders we developed a strategy of sequencing only the disease! The importance of posttest clinical correlation ordering physicians ( Figure 1a ) needs... Of clinically relevant variants were classified by following the American College of genetics! Genomics scientists assisted with the interactions between laboratory specialists and ordering physicians ( Figures 4a–d ) use for each College., Y. et al fell to $ 1,500 the known disease genes providing! For genetic variation of CACNA1H and childhood absence epilepsy that examines numerous genes simultaneously and sequencing subset! For variant identification unlikely that functional and strong cosegregation evidence exists for novel. Breakage syndromes case lasted for more than 4 months need reliable variant calls testing that modern day clinicians on... Disease-Causing variants detected in genes responsible for recessive disorders sequencing approach can overcome most of exome sequencing test cost... Mes-174 a & b ) the composition of a survey questionnaire San Diego CA. Data analysis pipeline panels provide advantages over clinical exome sequencing outcome time: 12 working days yields for patients different. Is often a side service offered by doctors trained in other specialties, as... Test results had an impact on diagnostic yield most of the 512 P/LP (! Patients referred for clinical whole-exome sequencing for the widespread use of whole exome sequencing approach to study disease. Endocrine clinic for short stature the WGL takes advantage of this practice CA ) according the! Minimal dependency on clinical expertise the types and distributions of pathogenic variants in phenotype-related genes in patients.